Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation
Desikan KR, Dhodapkar MV, Hough A, et al. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. Leuk Lymphoma 1997;27:315-319. (Pubitemid 27501190)
Multiple myeloma-associated amyloidosis is an indepen dent high-risk prognostic factor
Vela-Ojeda J, Garcia-Ruiz Esparza MA, Padilla-Gonzalez Y, et al. Multiple myeloma-associated amyloidosis is an indepen dent high-risk prognostic factor. Ann Hematol 2009;88:59-66.
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smouldering multiple myeloma
Siragusa S, Morice W, Gertz MA, et al. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smouldering multiple myeloma. Ann Hematol 2011;90:101-106.
Analysis of V-J expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (III) as a new amyloid-associated germline gene segment
DOI 10.1182/blood-2002-01-0114
Perfetti V, Casarini S, Palladini G, et al. Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identif es 3r (lambdaIII) as a new amyloid-associated germline gene segment. Blood 2002;100:948-953. (Pubitemid 34832622)